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Background: Gastric cancer exhibits familial clustering, and gastric cancer familial relatives (GCF) tend to present
with corpus-predominant gastritis and precancerous lesions as SPEM or IM after H. pylori infection. The study
determined whether the children of gastric cancer patients (GCA) had genomic single nucleotide polymorphisms
(SNPs) predisposed to the gastric precancerous lesions as spasmolytic polypeptide-expressing metaplasia (SPEM)
or intestinal metaplasia (IM).
Results: There were 389 family relatives of 193 non-cardiac GCA and 173 duodenal ulcer patients (DU), received
blood sampling for DNA collection. The differences of the risk alleles of SNPs in the ITGA5, ITGB1, IL-10, COX-2,
RUNX3, and TFF2 genes were compared between 195 children of GCA and 143 DU. The children of GCA had
higher allele frequencies of ITGA5-1160 T-carrier (P = 0.006, OR[95% CI] = 2.2[1.2-4]), ITGB1-1949 A-carrier (P = 0.047;
OR[95% CI] = 2.8[1.4-5.3]), ITGB1 + 31804 C-carrier (P = 0.013; OR[95% CI] = 4.7[1.7-13.0]), IL-10-592 AA (P = 0.014; OR
[95% CI] = 2.3[1.4-4.0]) and COX-2-1195 G-carrier (P = 0.019; OR[95% CI] = 1.7[0.9-3.2]) than DU. The combined genotype
with ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/A/C carriers and COX-2-1195/IL-10-592 as G-carrier/AA was more
prevalent in the children of GCA than in DU (P < 1×10−4), and predisposed with a 5.3-fold risk of getting SPEM in
the H. pylori-infected children of GCA (P = 0.016). Such risk of getting SPEM increased to 112 folds, if combined
with RUNX3 + 492/TFF2-308 as A-carrier/CC in this limited study scale (P = 1×10−4).
Conclusions: The SNPs of ITGA5-1160/ITGB1-1949/ ITGB1 + 31804 as T/A/C carriers and COX-2-1195/IL-10-592 as
G-carrier/AA, or more specific to combine RUNX3 + 492/TFF2-308 as A-carrier/CC shall be host factor predisposing to
gastric cancer during H. pylori infection, and serve as marker to identify high-risk subjects for H. pylori eradication.
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Helicobacter pylori is defined as a World Health
Organization type I carcinogen for gastric cancer [1,2].
H. pylori-infected patients may develop gastric cancer
after chronic gastritis with gastric atrophy, precancer-
ous lesions such as spasmolytic polypeptide expressing
metaplasia (SPEM) or intestinal metaplasia (IM), and
dysplasia [3-8]. Gastric cancer typically exhibits familial
clustering, and gastric cancer familial relatives (GCF)
tend to present with corpus-predominant gastritis and
precancerous lesions such as SPEM or IM after H. pyl-
ori infection [9-13]. Therefore, GCF can be recognized
as being at risk of gastric cancer, and such individuals
should receive H. pylori screening for early bacterial
eradication in order to prevent gastric cancer.
The reason why GCF can be at a higher risk of devel-
oping gastric cancer after H. pylori infection remains
uncertain. A more adverse interaction between host and
H. pylori virulence may exist in GCF to mediate gastric
carcinogenesis. The cagA-vacA-babA2 triple-positive H.
pylori isolates have been reported as carrying a high risk
of gastric cancer, and almost 100% of the H. pylori
strains are cagA-vacA-babA2 triple-positive in Taiwan
[14-18]. Therefore, GCF in Taiwan are optimal candi-
dates to investigate whether there is any host genomic
predisposition in such a high risk group for gastric can-
cer to determine the specific process of gastric carcino-
genesis. In contrast, the duodenal ulcer patients (DU)
developed by H. pylori infection is well recognized to
have a protective host phenotype having a low risk of
gastric adenocarcinoma [19]. By examining differences
in the selected candidate genes’ single nucleotide poly-
morphisms (SNPs) between GCF and DU, the study
could validate the SNPs potentially correlated to the
higher gastric cancer risk in GCF.
This study selected several potential candidate genes
for an analysis of SNPs, including those involved in the
specific interactions of bacterial virulence and host re-
ceptors related with gastric inflammation, precancerous
lesions, or even gastric carcinogenesis. We first included
the candidate genes ITGA5 and ITGB1, which encode
integrin α5β1 gastric epithelial cell surface receptors to
adhere with CagL of H. pylori to construct injection
apparatus to translocate CagA of H. pylori via the type
IV secretion system (T4SS) [20-22]. As H. pylori iso-
lates can directly prime α5β1 integrin of the host, and
as the activity of T4SS determines the risk of cancer
[20], we investigated whether any host genomic predis-
position in ITGA5 and ITGB1 existed in high-risk
GCF. We also included the interleukin-10 gene (IL-10)
and cyclooxygenase-2 gene (COX-2), both of which
participate in chronic inflammation and have been re-
ported to affect gastric cancer outcomes after H. pylori in-
fection [16,21-25]. There were two additional SNPs beingincluded, with the runt-related transcription factor 3 gene
(RUNX3) related to SPEM formation and intestinal-type
gastric cancer [26,27], and the trefoil factor 2 (TFF2) gene
expressed in SPEM during H. pylori-related gastric car-
cinogenesis [5,28].
The results showed that several candidate genes
(including ITGA5, ITGB1, IL-10, COX-2, RUNX3 and
TFF2) differed in the specific genotypes of SNPs between
GCF and DU, and predisposed to pre-cancerous lesion,
SPEM, within GCF. These specific genotypes of SNPs
may offer candidate markers to screen out those at high
risk of gastric cancer for early H. pylori eradication in a
large-scale study.
Methods
Patients and study designs
This study prospectively and consequently enrolled 389
family relatives of 193 non-cardiac gastric adenocarcin-
oma (GCA) index patients and 173 benign DU, all of
whom joined a screening project for H. pylori infection
(NHRI-EX101-9908 BI). A number of the subjects have
been referred from the recently published study by our
group [12], and the emerging increase of the additional
subjects were collected from the funding of the same
multi-component grant to fulfill the statistical power
required to answer the question whether or not any host
genomic predisposition in several candidate genes can
exist in the high-risk gastric cancer relatives different to
low-risk gastric cancer patients, and to correlate with
the presence of precancerous lesions with an increased
risk of gastric cancer, especially after H. pylori infection.
All of the enrolled study subjects provided written
informed consent before entering the study. Both the
consent form and study design were reviewed by the Re-
search Ethics Committee of National Cheng Kung Uni-
versity Hospital (certification code: HR-98-023). A flow
chart of patient enrollment and the familial relationships
to the GCA index patients are shown in Figure 1.
Among the 389 GCF, there were 61 spouses, 43 siblings,
205 children, 49 grandchildren and 31 other relatives.
Each of the enrolled subjects provided blood samples to
collect DNA.
The study at first selected the DNA of 195 children of
GCA and 143 DU controls to validate whether there
were any differences between these two groups with
regards to the predisposing risk alleles of SNPs in the
ITGA5, ITGB1, IL-10, COX-2, RUNX3, and TFF2 genes.
All of the 195 children of GCA were also screened for
H. pylori infection by the 13C-urea breath test. For DU,
the presence of H. pylori infection was confirmed by
positive histology results.
Of the 88H. pylori-infected children of GCA with a
positive 13C-urea breath test, 56 were invited to receive
gastric endoscopy to provide topographic gastric biopsy
Figure 1 The study flow chart of case recruitment to screen H. pylori infection. In total, 389 family relatives (GCF) from 195 non-cardiac
gastric cancer (GCA) index patients, including different familial relations, were enrolled. Blood sampling for DNA extraction and H. pylori screening
with the urea breath test (UBT) were performed in all 389 GCF. There were also 143 of 173 duodenal ulcer patients to receive blood sampling
and H. pylori screening. The differences in single nucleotide polymorphisms (SNPs) were compared between the DNA of 195 GCA children and
143 duodenal ulcer controls. Of the 88 H. pylori-infected children of GCA, 56 received endoscopy and topographical biopsies to assess whether
the corpus predominant gastritis index (CGI), atrophy (AT), spasmolytic polypeptide expressing metaplasia (SPEM) and intestinal metaplasia (IM)
correlated to the SNPs of ITGA5, ITGB1, IL-10, COX-2, RUNX3, and TFF2 identified from the comparison between the children of GCA and the
duodenal ulcer controls.
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corpus predominant gastritis index (CGI), atrophy,
SPEM, and IM as described in our previous studies
[12,17,29,30]. We further analyzed whether any SNPs
associated with specific histology features including
CGI, atrophy, SPEM and IM in the children of GCA.
Blood sampling and SNP identification
The genomic DNA of the participants was extracted
from peripheral blood mononuclear cells by the manu-
facturer’s instructions (Viogene, Taipei, Taiwan). The
genes of interest were divided into three groups: 1. in-
tegrin α5β1 encoding genes ITGA5 and ITGB1; 2. IL10
and COX-2 genes that participate in the inflammation
process; and 3. RUNX3, and TFF2 genes relating to late
carcinogenesis processes and metaplasia. Because no re-
ports about the relations of diseases for SNPs in ITGA5,
ITGB1, and TFF2 genes in previous literatures and their
allele frequencies in our population, we performed direct
sequencing of the promoters of ITGA5, ITGB1, and
TFF2 genes in 20 randomly-selected GCA offspring and
found the candidate SNPs for our study. The other can-
didate SNPs were identified based on those reported in
previous papers, tag SNPs, and those located on the pro-
moter, exon or 3’UTR. We assessed the candidate SNPs
with two-step polymerase chain reactions (PCR) and dir-
ect sequencing or restriction fragment length poly-
morphism (RFLP), real time PCR or MassARRAY iPLEX
Gold-SNP genotyping. The detailed methods of the iden-
tification for 24 candidate SNPs were listed in Additionalfile 1: Table S1, including ITGA5 (−1160 G/T;–240 C/T),
ITGB1 (−1949 A/G;–1840 C/T;–1660 -/TTTAA;–1575
A/G;–685-/C; +31804 C/G/T; +32492 A/G), IL-10
(−1082 A/G;–819 C/T;–592 A/C), COX-2 (−1195 A/G;
+8473 C/T), RUNX3 (−18508 C/G;–1714 A/C;–1582
C/T;–1166 C/T; +492 A/T; + 73375 A/C) and TFF-2
(−1373 C/T;–503 A/G;–308 A/C; +4649 A/G).
As in our previous study [31,32], we performed two-
step PCR with the following cycling conditions: 94°C for
5 minutes then 15 cycles at 94°C for 30 s, 66°C for 30 s,
and 72°C for 60 s; then 25 cycles at 94°C for 30 s, 61°C
for 30 s, and 72°C for 60 s, and final elongation at 72°C
for 10 minutes. The amplified products were sent for
direct sequencing (Genomics BioSci & Tech, Taipei,
Taiwan, with an ABI3730XL system) or RFLP with spe-
cific restriction enzymes (New England Biolabs, Inc.,
MA, United States). Some SNPs were identified with
real-time PCR. The real-time PCR in this study were
performed with TaqMan analysis (PE Applied Biosys-
tems, CA, USA), and the primers were designed by File
Builder software. PCR were performed in a 10-μl volume
containing 10 ng DNA, 2× Master Mix 5 μl, and 0.5 μl
probes. The amplification reaction profile included heat-
ing at 95°C for 10 minutes followed by 45 cycles at 95°C
for 15 s and 60°C for 60 s. The signal was acquired at
60°C during each cycle. The genotypes were analyzed by
SDS 21 software.
We also used a MassARRAY iPLEX Gold-SNP genotyp-
ing system to perform genotyping in addition to real-time
PCR, PCR-RFLP and direct sequencing. Genotyping with
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isolation, PCR amplification, clean resin, dispensing to
a SpectroCHIP bioarray and matrix-assisted laser desorp-
tion ionization time-of-flight mass spectrometry (MALDI-
TOF MS) analysis [33]. The assays were performed by
Feng Chi Biotech Corp. Taipei, Taiwan, with a Sequenom
MassARRAY system and analyzed by the Taipei Institute
of Pathology.
Endoscopy and topographic gastric histology grading
The GCA children with H. pylori infection proven by a
positive urea breath test were invited to receive endos-
copy and topographical biopsies for five specimens from
the antrum (x2), corpus (x2) and high corpus near to the
cardia (×1) to assess the related gastric histological fea-
tures [12,34-37]. Each specimen of the topographic site
was reviewed in a blinded manner by the pathologist,
and the presence of IM (absence: 0; presence: score 1–3)
and atrophy (absence: 0; presence: score 1–3) was
assessed according to the modified updated Sydney sys-
tem [38]. In this study, the presence of IM was strictly
defined as at least one gastric biopsy sample showing
metaplastic cells (goblet cells) involving at least 5% of
the upper third of the gastric mucosa [35-37]. Based on
the acute and chronic inflammation scores according to
the modified updated Sydney system, the presence of
CGI was defined as the occurrence of either: 1) the com-
bination of acute and chronic inflammation scores in the
high corpus being equal to or larger than the antrum,
but not equal to 1; or 2) the combination of scores in
the body being larger than the antrum. All of the other
conditions were defined as an absence of CGI, including
the combination of acute inflammation score and
chronic inflammation score of the antrum and high
corpus being equal to 1 [12].
TFF2 immunohistochemistry for SPEM
We performed TFF2 immunohistochemistry to assess
SPEM in the topographical tissues from the antrum, cor-
pus, and high corpus of the H. pylori-infected children
of non-cardiac gastric cancer patients. Immunohisto-
chemical staining was performed using mouse anti-
human spasmolytic polypeptide antibody (GE16C, Leica
Biosystem Newcastle Ltd., UK) and a commercial kit
(NovoLink™ Polymer Detection System, Leica Biosystem
Newcastle Ltd., UK). The protocol was modified from
the instructions of the manufacturer as used in our
previous study [17]. The presence of SPEM was defined
as glands formed by TFF2-expressing cells detected in
the specimens of either the corpus or high corpus as
described previously [12],17]. Because a whole layer
(including the upper, middle and lower portion of the
gland) of gastric mucosa is needed to assess SPEM. Any
cases where SPEM could not be evaluated were treatedas missing data [17]. Thus there were fewer case numbers
for the comparison of SPEM.
Statistics
The Student’s t test was used when appropriate to deter-
mine parametric differences such as age. We verified the
non-parametric proportions such as genomic frequen-
cies of specific SNPs in the GCF and DU patients using
mixed effect model with SAS PROC MIXED procedure
because the genomic frequencies of the GCF were famil-
ial dependent while most DU patients had independent
data. To correct multiple testing, permutation test by
SAS PROC MULTTEST procedure (20000–50000 per-
mutations) was used. We generated the odds ratios (OR)
and 95% confidence intervals (95% CI) between the GCF
and DU patients by logistic regression with the adjust-
ment of age and H. pylori infection. The linear-by-linear
association was applied to assess the frequencies change
of the risk SNPs in different familial relation groups. The
analyses of the Student’s t test, the logistic regression, and
the linear-by-linear association were performed using
SPSS version 17.0 for Windows (SPSS Inc., Chicago,
USA). The analyses of the mixed effect model and permu-
tation test were performed using SAS software version 9.3
(SAS Institute, Cary NC). All tests were 2-tailed with the
significance set at a P value of less than 0.05.
Results
The differences in the selected SNPs between children of
GCA and DU
In Figure 1, 195 children of GCA have provided DNA to
validate the differences in the SNPs of the ITGA5,
ITGB1, IL-10, COX-2, RUNX3, and TFF2 genes, as com-
pared to 143 DU controls. There was no difference in
gender between the 195 children of GCA and the 143
DU controls. However, children of GCA had a younger
mean age and a lower prevalence of H. pylori infection
than DU (Table 1). The children of GCA had a higher
allele frequencies of ITGA5-1160 T-carrier (79% vs. 65%;
P = 0.006), ITGB-1949 A-carrier (84% vs. 74%; P = 0.047),
ITGB1 + 31804 C-carrier (95% vs. 88%; P = 0.013), IL-
10-819 TT (52% vs. 38%; P = 0.014), IL-10-592 AA (52%
vs. 38%; P = 0.014) and COX-2-1195 G-carrier (83% vs.
71%; P = 0.019), as compared with DU controls. How-
ever, there were no differences in the allele frequencies
of the SNPs in the RUNX3 and TFF2 genes between the
children of GCA and DU controls (Table 1).
Combined predisposing SNPs to differentiate between
GCA children and DU
Based on the P values of permutation tests, we choose
SNPs in each gene most significantly different between
the case and control groups to derive combined genotypes
for further analysis. The study tested the differences of the
Table 1 The differences of the single nucleotide polymorphisms in the ITGA5, ITGB1, IL10, COX-2, RUNX3, and TFF2
genes between 195 children of gastric cancer patients and 143 duodenal ulcer patients
Parameters N (%) GCA children DU patients P* P** OR (95% CI)
Age (yr) 38.2 ± 10.6 49.2 ± 13.8 1×10-4
Gender (F: M) 99 (51): 96 (49) 59 (41): 84 (59) 0.050 0.096 1.5 (1.0 - 2.3)
H. pylori (+: -) 88 (48): 97 (52) 110 (79): 29 (21) <1×10-4 <1×10-4 0.2 (0.1 - 0.4)
ITGA5
ITGA5 -1160 (N = 195) (N = 139)
T-carrier: GG 154 (79): 41 (21) 90 (65): 49 (35) 0.017 0.006 2.2 (1.2 - 4.0)
ITGA5 -240 (N = 193) (N = 138)
CC: CT 190 (98): 3 (2) 136 (99): 2 (1) 0.751 1.000 0.3 (0.0 - 3.1)
ITGB1
ITGB1 -1949 (N = 189) (N = 136)
A-carrier: GG 158 (84): 31 (16) 101 (74): 35 (26) 0.047 0.047 2.8 (1.4 - 5.3)
ITGB1 -1840 (N = 189) (N = 136)
CC: T-carrier 100 (53): 89 (47) 75 (55): 61 (45) 0.872 0.735 0.9 (0.6 - 1.6)
ITGB1 -1575 (N = 189) (N = 136)
AA: G-carrier 10 (5): 179 (95) 15 (11): 121 (89) 0.034 0.059 0.3 (0.1 - 0.8)
ITGB1 -685 (N = 185) (N = 126)
-/-: -/C 26 (14): 159 (86) 13 (10): 113 (90) 0.633 0.386 1.5 (0.7 - 3.4)
IGB1 -1660 (N = 192) (N = 138)
TTTAA/TTTAA: others 165 (86): 27 (14) 117 (85): 21 (15) 0.385 0.877 0.9 (0.5 - 1.7)
ITGB1 +31804 (N = 189) (N = 136)
C-carrier: TT 180 (95): 9 (5) 119 (88): 17 (13) 0.003 0.013 4.7 (1.7 - 13.0)
ITGB1 +32492 (N = 189) (N = 136)
G-carrier: AA 97 (51): 92 (49) 57 (42): 79 (58) 0.022 0.113 1.7 (1.0 - 2.9)
IL10
IL10 -1082 (N = 190) (N = 138)
AA: G-carrier 172 (91): 18 (9) 121 (88): 17 (12) 0.216 0.839 1.7 (0.7 - 3.9)
IL10 -819 (N = 193) (N = 138)
TT: C-carrier 101 (52): 92 (48) 53 (38): 85 (62) 0.022 0.014 2.3 (1.4 - 4.0)
IL10 -592 (N = 193) (N = 138)
AA: C-carrier 101 (52): 92 (48) 53 (38): 85 (62) 0.022 0.014 2.3 (1.4 - 4.0)
COX-2
COX-2 -1195 (N = 189) (N = 129)
G-carrier: AA 156 (83): 33 (17) 92 (71): 37 (29) 0.064 0.019 1.7 (0.9 - 3.2)
COX-2 +8473 (N = 194) (N = 138)
TT: C-carrier 134 (69): 60 (31) 84 (61): 54 (39) 0.259 0.129 1.4 (0.9 - 2.3)
RUNX3
RUNX3 -18508 (N = 186) (N = 135)
C-carrier: GG 130 (70): 56 (30) 100 (74): 35 (26) 0.586 0.449 0.7 (0.4 - 1.2)
RUNX3 -1714 (N = 193) (N = 137)
CC: A-carrier 109 (56): 84 (44) 68 (50): 69 (50) 0.302 0.261 1.3 (0.7 - 2.1)
RUNX3 -1582 (N = 189) (N = 136)
T-carrier: CC 84 (44): 105 (56) 69 (51): 67 (49) 0.338 0.307 0.9 (0.5 - 1.4)
RUNX3 -1166 (N = 193) (N = 137)
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Table 1 The differences of the single nucleotide polymorphisms in the ITGA5, ITGB1, IL10, COX-2, RUNX3, and TFF2
genes between 195 children of gastric cancer patients and 143 duodenal ulcer patients (Continued)
TT: C-carrier 109 (56): 84 (44) 68 (50): 69 (50) 0.302 0.258 1.3 (0.7 - 2.1)
RUNX3 +492 (N = 189) (N = 136)
TT: A-carrier 106 (56): 83 (44) 67 (49): 69 (51) 0.312 0.263 1.2 (0.7 - 2.1)
RUNX3 +73375 (N = 189) (N = 135)
CC: A-carrier 45 (24): 144 (76) 23 (17): 112 (83) 0.122 0.167 1.5 (0.8 - 2.9)
TFF2
TFF2 -1373 (N = 189) (N = 136)
CC: T-carrier 139 (74): 50 (26) 97 (71): 39 (29) 0.692 0.702 1.0 (0.6 - 1.8)
TFF2 -503 (N = 189) (N = 136)
AA: G-carrier 139 (74): 50 (26) 97 (71): 39 (29) 0.692 0.706 1.0 (0.6 - 1.8)
TFF2 -308 (N = 189) (N = 136)
CC: A-carrier 85 (45): 104 (55) 53 (39): 83 (61) 0.394 0.311 1.2 (0.7 - 2.1)
TFF2 +4649 (N = 188) (N = 136)
GG: A-carrier 100 (53): 88 (47) 64 (47): 72 (53) 0.343 0.308 1.4 (0.8 - 2.4)
GCA: gastric cancer. DU: duodenal ulcer. SNPs: single nucleotide polymorphisms. *P value by mixed effect model. **P value by permutation test.
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α5β1 encoding genes ITGA5, ITGB1 -1949 and ITGB1
+31804, implicating the influence of integrin α5β1 on
host-bacterial interaction processes during gastric carcino-
genesis, between the children of GCA and DU controls
(Table 2). The children of GCA had a 5-fold higher risk to
have all of the three risk SNPs (ITGA5 -1160 T-carrier,
ITGB1 -1949 A-carrier, and ITGB1 +31804 C-carrier), as
compared with DU (67% vs. 47%; P = 0.05). Because of the
linkage of disequilibrium between IL-10 -819 and IL-10
-592, this study selected IL-10 -592 to combine with COX-
2 -1195 to indicate a possibly more severe gastric inflam-
mation. This study illustrates that the children of GCA
exerted a 3.3-fold higher risk to harbor a combined SNPs
in IL-10-592/ COX-2-1195 as AA/G-carrier than DU
controls (43% vs. 25%; P = 0.005) (Table 2).
We further combined the above two sets to increase
the relative risk to differentiate the children of GCA
children to DU. Also in Table 2, the children of GCA
had a 8.0-fold higher risk (P < 1×10−4) to have a com-
bined genotype with ITGA5-1160/ITGB1-1949/ ITGB1
+ 31804 as T/A/C carriers and COX-2-1195/IL-10-592 as
G-carrier/AA than DU controls. To simplify the com-
bination, we selected the SNPs most significantly differ-
ent allele frequencies between GCA children and DU
controls, ITGA5 -1160 T-carrier and IL-10 -592 AA, to
serve as risk genotypes. The children of GCA had a 4.6-
fold risk of having both risk genotypes as compared to
DU controls (P < 1×10−4).
The combined SNPs correlate to SPEM in children of GCA
In Figure 1, 56 children of GCA with H. pylori infection
received endoscopy to assess the histology features. Thestudy illustrated the combined genotype with ITGA5-
1160/ITGB1-1949/ITGB1 + 31804 as T/A/C carriers and
COX-2-1195/IL-10-592 as G-carrier/AA correlated to
the presence of SPEM (P = 0.016), but not CGI, atrophy
or IM (P > 0.05). The children of GCA with the com-
bined genotype with ITGA5-1160/ITGB1-1949/ITGB1 +
31804 as T/A/C carriers and COX-2-1195/IL-10-592 as
G-carrier/AA had a 5.25-fold higher risk to have SPEM
(P = 0.016) (Table 3). Although the children of GCA had
a 4.6-fold higher chance of being ITGA5-1160/IL-10-592
as T-carrier/AA, but such a simplified combined geno-
type did not correlate to CGI, atrophy, SPEM or IM
(P > 0.05).
Since RUNX3 and TFF2 regulate the SPEM formation
during gastric carcinogenesis [26-28], we further tested
if any specific SNPs in RUNX3 and TFF2 genes corre-
lated to the presence of SPEM in the children of GCA.
In Table 4, the children of GCA with SPEM had a higher
allele frequencies of RUNX3 + 492 as A-carrier (53% vs.
22%; P = 0.042) and TFF2-308 as CC (60% vs. 28%; P =
0.041) than those without SPEM. Thus we further ana-
lyzed the combined genotypes of these 2 SNPs. Nearly
90% of the children of GCA with SPEM were either
RUNX3 + 492 A-carrier or TFF2-308 CC and these two
genotypes led to a 11.3-fold increased risk of having
SPEM in the children of GCA (P = 0.001) (Table 4).
However, there was no significant correlation between
the ITGA5-1160/ITGB1-1949/ITGB1 + 31804/COX-2-1195/
IL-10-592 as T-carrier/A-carrier/C-carrier/G-carriers/
AA and the RUNX3 + 492/ TFF2-308 as A-carrier/CC
among the children of GCA. By combining these two
sets of SNPs, the risk of getting SPEM within children
of GCA elevated up to 112 folds (P < 1×10−4) (Table 5).
Table 2 The comparisons of the genomic difference in the combinations of ITGA5 -1160 T-carrier, ITGB1 -1949
A-carrier, ITGB1 +31804 C-carrier, IL10 -592 AA and COX-2 -1195 G-carrier between the children of gastric cancer
patients and the duodenal ulcer controls
Predisposing SNPs Risk SNPs N (%) GCA children DU controls P* P** OR (95% CI)
ITGA5 -1160 (N = 189) (N = 134)
T-carrier 3R:2R:1R:0R 126(67): 49(26): 12(6): 2(1) 63(47): 48(36): 18(13): 5(4) 0.002
ITGB1 -1949
A-carrier 3R 126 (67) 63 (47) 0.225 0.050 5 (0.9 - 26.5)
ITGB1 +31804 2R 49 (26) 48 (36) 0.539 0.514 2.6 (0.5 - 13.8)
C-carrier 1R 12 (6) 18 (23) 0.575 0.756 1.7 (0.3 - 10.0)
0R 2 (21) 5 (4) 1
COX-2 -1195 (N = 188) (N = 125)
G-carrier 2R: 1R: 0R 80 (43): 93 (49): 15 (8) 31 (25): 75 (60): 19 (15) 0.013
With or without
IL-10 -592 AA 2R 80 (43) 31 (25) 0.021 0.005 3.3 (1.5 - 7.2)
1R 93 (49) 75 (60) 0.457 0.344 1.6 (0.7 - 3.3)
0R 15 (8) 19 (15) 1
ITGA5-1160 (N = 185) (N = 124)
T-carrier 2R: 1R: 0R 44 (24): 115 (62): 26 (14) 10 (8): 67 (54): 47 (38) <1×10-4
ITGB1 -1949
A-carrier
ITGB1 +31804 2R 44 (24) 10 (8) <1×10-4 <1×10-4 8.0 (3.4 - 18.4)
C-carrier 1R 115 (62) 67 (54) 2×10-4 3×10-4 3.1 (1.8 - 5.5)




(N = 193) (N = 135)
IL-10 -592 AA 2R: 1R: 0R 74 (38): 105 (54): 14 (7) 33 (24): 73 (54): 29 (21) 4×10-4
With or without
ITGA5 -1160 2R 74 (38) 33 (24) 1×10-4 <1×10-4 4.6 (2.2 - 9.9)
T-carrier 1R 105 (54) 73 (54) 6×10-4 0.003 3.0 (1.5 - 6.0)
0R 14 (7) 29 (21) 1
GCA: gastric cancer. DU: duodenal ulcer. SNPs: single nucleotide polymorphisms. 3R: the presence of 3 predisposing SNPs with risk alleles. 2R: the presence of 2
predisposing SNPs with risky alleles.
1R: the presence of 1 predisposing SNP with risk allele. 0R: no any predisposing SNPs with risk alleles. *P value by mixed effect model; **P value by
permutation test.
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familial relative groups of GCA
We further assessed whether the different gastric cancer
familial relative groups had different proportions of the
combined SNPs predisposing to SPEM. In Figure 2A,
the offspring, including children and grandchildren, of
GCA had a higher rate of ITGA5-1160/ITGB1-1949/
ITGB1 + 31804/COX-2-1195/IL-10-592 as T-carrier/A-
carrier/C-carrier/G-carriers/AA than other familial groups
(P = 0.018). However, in Figure 2B, there was no difference
in the combined genotype of RUNX3 + 492/TFF2-308 as
A-carrier/CC among the different familial groups of GCA(P = 0.313). Furthermore, children of the GCA index
patients carrying the combination sets of ITGA5-1160/
ITGB1-1949/ITGB1 + 31804/COX-2-1195/IL-10-592 as
T-carrier/A-carrier/C-carrier/G-carriers/AA also had a
higher prevalence of the same combination SNPs than
children of GCA index patients not carrying such com-
binations of SNPs (43% vs. 16%; P = 0.003; OR 3.9; 95%
CI: 1.6-9.6).
Discussion
There were genomic predispositions of SNPs in the
ITGA5, ITGB1, IL-10 and COX-2 genes in the children
Table 3 The difference of the H. pylori-related histological features between the children of gastric cancer patients
with and without the risk allele genotypes as ITGA5-1160 T-carrier/ITGB1-1949 A-carrier/ITGB1+31804 C-carrier &
COX-2-1195 G-carrier/IL10-592 AA
Risks N (%) Pathology ITGA5-1160/ITGB1-1949/ITGB1+31804/COX-2-1195/IL10-592
as T*/A*/C*/G*/AA
Others P* P** OR (95% CI)
CGI (N = 56)
Present: absent 14 (58): 10 (42) 15 (47): 17 (53) 0.115 0.429 1.6 (0.5-4.6)
Atrophy (N = 56)
Present: absent 17 (71): 7 (29) 21 (66): 11 (34) 0.932 0.778 1.3 (0.4-4.0)
SPEM (N = 48)
Present: absent 18 (82): 4 (18) 12 (46): 14 (54) 0.010 0.016 5.3 (1.4-19.8)
IM (N = 56)
Present: absent 4 (17): 20 (83) 6 (19): 26 (81) 0.831 1.000 0.9 (0.2-3.5)
CGI: corpus predominant gastritis index. SPEM: spasmolytic polypeptide-expressing metaplasia. IM: intestinal metaplasia. *Indicated the carrier of the specific allele
in SNPs. *P value by mixed effect model; **P value by permutation test.
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cancer after H. pylori infection. The combined genotype
as ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/A/C
carriers and COX-2-1195/IL-10-592 as G-carrier/AA sig-
nificantly predisposed to the precancerous lesions such
as SPEM after H. pylori infection in children of GCA.
Such a predisposing risk of SPEM can be elevated via
combination with RUNX3 + 492/TFF2-308 as A-carrier/
CC in children of GCA. The combined genotype such
as ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/A/C
carriers and COX-2-1195/IL-10-592 as G-carrier/AA, or
even more specifically combined with RUNX3 + 492/
TFF2-308, may thus serve as a host factor to identify the
risk group of gastric cancer for an early H. pylori
eradication.
The study utilized patients with duodenal ulcers to
serve as cohort controls with the least gastric cancer
risk. In a review of the related literature, gastric cancer
relatives have been recognized as having an increased
gastric cancer risk. Gastric cancer relatives exist with a
genomic predisposition to gastric cancers, especially
after H. pylori infection. The study thus attempted to
illustrate whether the possible candidate genomic poly-
morphisms selected in this study can be different
between our high-risk gastric cancer relatives and low-
risk duodenal ulcer patients in either Tables 1 and 2. In
this study, the children of GCA had a younger mean age
than DU patients, whose mean age was compatible to
that of DU in a previous study [19]. Thus, our enrolled
DU patients were found to be suitable to serve as the
low-cancer risk comparison group.
The activity of T4SS mediated by H. pylori positively
associated with the risk of gastric cancer [20]. Further-
more, we disclosed that H. pylori isolates with the cagL
amino acid sequence polymorphism Y58E59 could ex-
ploit higher amounts of gastric integrin α5β1 to mediate
stronger T4SS activity [39,40]. Namely, more toxic H.pylori isolates shall have mediated with higher gastric
cancer risk via the host integrin α5β1 expressions. The
current study showed that the children of GCA, who are
at a high risk of gastric cancer, can express with a 5-fold
higher risk to be ITGA5-1160/ITGB1-1949/ITGB1 +
31804 as T/A/C carriers in ITGA5 and ITGB1 than DU
(Table 2). This suggests that there should be a host
predisposition to regulate the expression of the putative
integrin α5β1 in addition to the virulence factor of H.
pylori isolates. Thus, it would be worthwhile to validate
the correlation of ITGA5 and ITGB1 genes to the H.
pylori-related histological precancerous changes, especially
among children of GCA.
The current study also identified that the children of
GCA patients as having a higher prevalence of IL-10-819
as TT and IL-10-592 as AA than DU, compatible with
previous findings to show such genotypes with lower
IL-10 excretion and more severe gastritis [21-23,41].
COX-2 over-expression can be evident in pre-malignant
gastric lesions after H. pylori infection [11,24,25]. Our
data showed that the children of GCA had a higher
prevalence of COX-2-1195 G-carrier than DU, but the
finding is not compatible with a previous study, which
suggests that the COX-2-1195 AA genotype carries a
higher risk of GCA [42]. This may also be due to poten-
tial ethnic differences, or that the COX-2-1195 G-carrier
may just serve to associate with other pathways of
gastric carcinogenesis [43].
Because gastric carcinogenesis is a multi-step and
multi-factorial process, we anticipate that SNPs on dif-
ferent genes work in concert in the gastric carcinogen-
esis. We choose TagSNPs in each gene as the most
significantly different between the GCF and the DU
patients for the analysis of combined genotypes. We
found that the children of GCA had an 8-fold risk to
have the combined genotypes of either a complicated
model (ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/
Table 4 The differences of the single nucleotide polymorphisms in the RUNX3, and TFF2 genes between children of
gastric cancer patients with (N = 31) or without (N = 18) SPEM
Parameters N (%) SPEM (+) SPEM (-) P* P** OR (95% CI)
Age (yr) 39.9 ± 7.7 38.2 ± 11.3 0.312
Gender (F: M) 20 (65): 11 (35) 7 (39): 11 (61) 0.092 0.136 2.9 (0.9 - 9.5)
RUNX3
RUNX3 -18508 (N = 29) (N = 17)
C-carrier: GG 21 (72): 8 (28) 12 (71): 5 (29) 0.897 1.000 1.1 (0.3 - 4.1)
RUNX3 -1714 (N = 31) (N = 18)
A-carrier: CC 16 (52): 15 (48) 4 (22): 14 (78) 0.044 0.067 3.7 (1.0 - 13.9)
RUNX3 -1582 (N = 30) (N = 18)
T-carrier: CC 16 (53): 14 (47) 5 (28): 13 (72) 0.085 0.137 3.0 (0.8 - 10.4)
RUNX -1166 (N = 31) (N = 18)
C-carrier: TT 16 (52): 15 (48) 4 (22): 14 (78) 0.044 0.070 3.7 (1.0 - 13.9)
RUNX3 +492 (N = 30) (N = 18)
A-carrier: TT 16 (53): 14 (47) 4 (22): 14 (78) 0.035 0.042 4.0 (1.1 - 15.0)
RUNX3 +73375 (N = 30) (N = 18)
C-carrier: AA 21 (70): 9 (30) 14 (78): 4 (22) 0.613 0.741 0.7 (0.2 - 2.6)
TFF2
TFF2 -1373 (N = 30) (N = 18)
C-carrier: TT 30 (100): 0 (0) 17 (94): 1 (6) 0.206 0.377 2.6 (0.8 - 9.2)
TFF2 -503 (N = 30) (N = 18)
AA: G-carrier 23 (77): 7 (23) 10 (56): 8 (44) 0.127 0.194 2.6 (0.7 - 9.2)
TFF2 -308 (N = 30) (N = 18)
CC: A-carrier 18 (60): 12 (40) 5 (28): 13 (72) 0.022 0.041 3.9 (1.1-13.8)
TFF2 +4649 (N = 30) (N = 18)
G-carrier: AA 26 (87): 4 (13) 17 (94): 1 (6) 0.419 0.637 0.4 (0.1-3.7)
RUNX3+492/TFF2-308
A-carrier/CC
2R 7 (23) 1 (6) 0.001 0.009 23.3 (2.0 - 273.3)
1R 20 (67) 7 (39) 0.001 0.004 9.5 (2.0 - 44.9)
0R 3 (10) 10 (56) 1
2R+1R:0R 27 (90): 3 (10) 8 (44): 10 (56) 3×10-4 0.001 11.3 (2.5 - 51.0)
SPEM: Spasmolytic polypeptide-expressing metaplasia; SNPs: single nucleotide polymorphisms. 2R: the presence of 2 predisposing SNPs with risk alleles. 1R: the
presence of 1 predisposing SNP with risk allele. 0R: no any predisposing SNPs with risk alleles. *P value by mixed effect model; **P value by permutation test.
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AA) (Table 2), higher than the risk difference of each
single SNP. This suggests that when more risk alleles
combine, the higher the risk of gastric cancer. Neverthe-
less, only the first complicated model can be related to
the presence of the precancerous lesions as SPEM in the
children of GCA (Table 3). It thus suggested the compli-
cated model with 5 risk alleles shall be a novel host fac-
tor to determine the high-risk patients of gastric cancer
for early H. pylori eradication.
The combined genotypes ITGA5-1160/ITGB1-1949/
ITGB1 + 31804 as T/A/C carriers and COX-2-1195/IL-
10-592 as G-carrier/AA can just correlate with SPEM,but not IM. The lack of correlation to IM may be due to
the small number of cases with IM or the younger mean
age in our series, or to fulfill SPEM is generally earlier
than IM [6,44,45].
In Table 4, the combined genotype of RUNX3 + 492/
TFF2-308 as A-carrier/cm3 was also correlated to the
presence of SPEM in the children of GCA. Accordingly,
combining these 2 sets of risk combined genotypes, the
risk to get SPEM increased up to 112 folds (Table 5).
This indicated these 2 sets of combined genotypes can
be synergistic to enhance the SPEM. With regards to no
significant difference of allele frequencies of SNPs in
RUNX3 and TFF2 genes between the children of GCA
Table 5 The risk of SPEM increases stepwise for ITGA5-1160 T-carrier, ITGB1-1949 A-carrier, ITGB1+31804 C-carrier,
COX-2-1195 G-carrier, and IL10-592 AA to combine with RUNX3 +492 as A-carrier & TFF2-308 as CC in the children of
gastric cancer patients
Predisposing SNPs Risk SNPs N (%) SPEM (+) SPEM (−) P* P** OR (95% CI)
ITGA5-1160/ITGB1- 2R: 1R: 0R 16 (53): 13 (43): 1 (3) 1 (6): 10 (56): 7 (39) <1×10−4
1949/ITGB1+31804/COX-2-1195/IL10-592 2R: 1R+ 0R 16 (53): 14 (47) 1 (6): 17 (94) 5×104 0.001 19.4 (2.3-165.2)
as T*/A*/C*/G*/AA
2R+ 1R: 0R 29 (97): 1 (3) 11 (61): 7 (39) 5×10−4 0.003 18.5 (2.0-167.8)
with or without
2R 16 (53) 1 (6) 1×10−4 1×10−4 112.0 (6.1-2057.3)
RUNX3+492/TFF2-308 1R 13 (43) 10 (56) 0.045 0.0518 9.1 (1.0-86.5)
as A*/CC 0R 1 (3) 7 (39) 1
SPEM: spasmolytic polypeptide-expressing metaplasia. SNPs: single nucleotide polymorphisms. 2R: the presence of 2 predisposing SNPs with risk alleles. 1R: the
presence of 1 predisposing SNPs with risk allele. 0R: no any predisposing SNPs with risk alleles. *Indicated the carrier of the specific allele in SNPs. *P value by
mixed effect model; **P value by permutation test.
Figure 2 The combined risk genotypes’ distribution in gastric
cancer familial relatives. A. The prevalences of the ITGA5-1160/
ITGB1-1949/ITGB1 + 31804 as T-carrier/A-carrier/C-carrier and COX-2-
1195/IL10-592 as G-carrier/AA among different GCA familial relative
groups were shown. The children of gastric cancer patients had
higher prevalence of the presence of either or both risk combination
SNPs in ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/A/C carriers and
COX-2-1195/IL-10-592 as G-carrier/AA than other familial relative
groups (P = 0.018). B. There were no difference in the combined
genotype of RUNX3 + 492/TFF2-308 as A-carrier/cm3 among different
familial groups of gastric cancer patients (P = 0.313).
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by integrin α5β1 and the chronic inflammation regulated
by IL-10 and COX-2 may be prior to the regulation of
RUNX3 and TFF2 in the gastric carcinogenesis process.
The allele frequencies of the combination of ITGA5-
1160/ITGB1-1949/ITGB1 + 31804 as T-carrier/A-carrier/
C-carriers in GCA children was 67%, which was higher
than 47% in DU patients (P = 0.0007). When taking
more SNPs with COX-2-1195/IL-10-592 and RUNX3/
TFF2 into consideration, the allele frequencies of the
complicated model (ITGA5-1160/ITGB1-1949/ITGB1 +
31804 as T/A/C carriers, COX-2-1195/IL-10-592 as
G-carrier/AA, and RUNX3/TFF2 as A-carrier/cm3)
remained higher in children of GCA than in DU (17%
vs. 6%, P = 0.003). This data suggests the greater num-
ber of risk SNPs included, the more specific the result
to indicate who the high risk group was.
The study has limitations to consider such as that it
does not divide the H. pylori-positive and negative
offspring of gastric cancer into analysis due to the case
scales. Furthermore, another limitation of the study is
the small sample size, especially the GCF with available
pathology data. This made the significance of the risk
combined genotypes to correlate with SPEM limited
despite there being a high odds ratio. This was because
many GCF were unwilling to receive gastric endoscope
examination although we screened 389 GCF and 205
children of non-cardiac GCA patients as outlined in
Figure 1. This indicated a lack of insight into the general
population, even with GCF having high GCA risks. It
also highlights the importance of studying markers to
identify high-risk groups of GCA. We do agree if bud-
geting allows, eradicating H. pylori infection for all off-
spring of gastric cancer patients remains ideal. If we can
understand the genomic predispositions from offspring
with a higher risk of having an adverse outcome, such
host factors may be helpful to screen out the general
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vent gastric cancer. The relevance of this study is that it
answers the reason why offspring of gastric cancer are at
risk, and that it also provides clinicians with a potential
tool to help screen out the higher risk groups with
obvious cost-benefit concerns.
Conclusions
There were SNPs in the ITGA5, ITGB1, IL-10, and
COX-2 genes in the children of GCA. The combined ge-
notypes ITGA5-1160/ITGB1-1949/ITGB1 + 31804 as T/
A/C carriers and COX-2-1195/IL-10-592 as G-carrier/
AA could determine the risk of SPEM after H. pylori
infection. Such risk can be elevated up to 112-fold by
combining RUNX3 + 492/TFF2-308 as A-carrier/cm3.
The host genomic SNPs shall be novel to identify the
high-risk patients of gastric cancer for early H. pylori
eradication.
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